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Levels of anti-inflammatory activity exhibited by
Eucomis autumnalis autumnalis were affected by the
environmental conditions during the period of winter dor-
mancy. Bulbs stored at low temperatures (10°C) showed
a limited period of time during which the anti-inflamma-
tory activity of the bulb extracts was higher than that of
the control. This effect was evident for a longer period in
the leaves. Extracts prepared from E. autumnalis (sub-
species autumnalis) bulbs, which were removed from the
soil and stored at 8–10°C during the winter months,
exhibited significantly higher COX-1 inhibitory activity
than those extracts prepared from control bulbs main-
tained in the soil in a greenhouse (15–24°C) during win-
ter, and from bulbs stored dry in paper bags (±18°C). A
second harvest, performed on plants that had been
returned to the soil after winter storage, was conducted
half-way through the growing season. Higher COX-1
inhibitory activity was observed in the leaf extracts from
the plants subjected to cold storage, than in the extracts
from plants stored dry or in the greenhouse. No signifi-
cant difference was observed at this stage between the
activity of the bulb and root extracts from the different
treatments. All extracts were prepared at a concentration
of 250μg ml-1 for comparison.
The potency of medicinal plants can be affected by a number
of factors including biochemical variation within individual
species, and external factors such as climate, soil conditions
and season (Prance 1995, Tunón et al. 1995). Changes to
the environment can cause modifications in plant growth and
development, which in turn can often result in changes in the
natural product content (Màthé 1988). Plants thus do not
consistently produce the same chemicals, in the same quan-
tities (Prance 1995). This has long been recognised by tradi-
tional healers in southern Africa. Factors such as locality,
season, slope aspect, soil type and moisture, and the time of
day, influence the choice and harvest of medicinal plants by
experienced gatherers and healers (Van Wyk et al. 1997).
Eucomis L’Herit is a genus of deciduous geophytes,
indigenous to southern Africa (Baker 1897, Pienaar 1984,
Compton 1990). The genus belongs to the family
Hyacinthaceae, and is classed in the order Asparagales
(Dahlgren et al. 1985, Compton 1990). The genus compris-
es about thirteen species (Hutchings et al. 1996), with the
species E. autumnalis further divided into three subspecies,
autumnalis; amaryllidifolia and clavata (Reyneke 1980). The
species are mostly summer-growing and become dormant in
winter (Du Plessis and Duncan 1989). The bulbs are of great
value in African traditional medicine, and are heavily har-
vested for trade in South Africa’s ‘muthi’ markets (Roberts
1990, Van Wyk et al. 1997).
The high rate of harvest of Eucomis species has seri-
ously depleted natural populations in southern Africa
(Cunningham 1988). Eucomis species propagate from
seeds and from bulb offsets, but the rate of natural propa-
gation is insufficient to sustain, or increase, population size
in the wild. Species such as E. bicolor are classed as threat-
ened in South Africa. The wide interest in this genus as an
ornamental plant led to the cultivation of several species in
Europe, and more recently locally in South Africa. In the
southern African context the plant’s value is enhanced by
the medicinal importance of the genus. Eucomis species are
hardy geophytes, bearing attractive inflorescences. The
plants show great horticultural potential, and would conceiv-
ably form a profitable small scale crop for both the horticul-
tural market and the medicinal plant trade.
The commercial production of Eucomis species in Europe
is purely for their ornamental value. Bulb production is, how-
ever, low (approximately 700 to 1 000 bulbs per acre). Bulb
harvesting of commercial bulbs and planting stock takes
place in November in the Northern Hemisphere. After lifting,
bulbs are stored between 13–20°C in a well ventilated room
during winter. Bulbs are maintained during storage and trans-
port in frost-free conditions (De Hertogh and Le Nard 1993).
Of the genera in the family Hyacinthaceae used in Zulu
medicine, most are considered highly toxic. Genera includ-
ing Bowiea, Scilla and Urginea contain cardiotoxic glyco-
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sides (Hutchings et al. 1996). Scilla natalensis Planch.,
which is used as an anti-inflammatory, additionally contains
homoisoflavonoids which are thought to be responsible for
this pharmacological activity (Van Wyk et al. 1997). While
Eucomis species are suspected of causing human and live-
stock poisoning (Watt and Breyer-Brandwijk 1962), no car-
diac glycosides have been found in the plants (Hutchings et
al. 1996). The genus Eucomis does contain saponins (Watt
and Breyer-Brandwijk 1962) benzopyrones, steroidal triter-
penoids and homoisoflavonoids (Van Wyk et al. 1997).
Traditional remedies prepared from Eucomis extracts are
used to treat a variety of ailments which exhibit symptoms of
pain and inflammation. Previous studies (Jäger et al. 1996,
Taylor and Van Staden 2001a) have indicated the presence
of cyclooxygenase-1 (COX-1) inhibitors in both aqueous and
ethanol extracts of Eucomis plant parts (leaf, bulb, root).
The domestication and cultivation of medicinal plants from
the wild is a complex process and cannot be achieved by
simply transferring the plants from their natural habitats to
cultivated fields. Environmental conditions in the new, for-
eign location, in the form of cultivated fields or greenhouses,
potentially alter both the suitability of the plant for cultivation
and the levels and/or type of the phytochemicals (Màthé
1988). For this reason several studies have been undertak-
en, using E. autumnalis autumnalis as the test species, to
determine the effects of factors such as age, season and
growth conditions on the levels of COX-1 inhibitors in the dif-
ferent plant parts (Taylor and Van Staden 2001b). In addi-
tion, micropropagated plants were tested for levels of COX-
1 inhibitors in comparison to field specimens (Taylor and Van
Staden 2001c). The aim of this particular study was to ascer-
tain the influence of storing the dormant bulbs under differ-
ent conditions during the winter months on the anti-inflam-
matory activity of extracts prepared at the beginning of
spring and half way through the growing season.
Materials and Methods
Plant material
Uniform specimens of Eucomis autumnalis autumnalis (Mill.)
Chitt. Reyn., grown originally from micropropagated stock,
were collected at the end of summer, once the foliage had
died back. Eight specimens were stored dry in brown paper
bags in the potting shed (18 ± 2°C), eight were stored dry in
a coldroom (10 ± 1.5°C) and eight were replaced into a
soil/sand mix and returned to the greenhouse (15–24°C). All
specimens were dusted with Bexadust® to discourage fungal
growth. One harvest was performed at the end of the winter
season and one mid-way through the growing season, when
the bulbs had developed leaves.
Extraction
Harvested specimens were divided into leaf, bulb and root
material, weighed to determine fresh mass, and dried at
50°C for three days. The different plant parts were each
ground to a fine powder and 500mg samples were extracted
in ethanol (20ml) using a sonication bath (30min). The
extracts were filtered through Whatman No 1 filter paper and
dried under vacuum at 35°C. Samples were resuspended in
ethanol (10mg ml-1) and were tested for inhibitory activity in
the COX-1 assay.
Cyclooxygenase (COX) Assay
The COX-1 assay was performed as described by White
and Glassman (1974), with minor modifications by Jäger et
al. (1996). Ten microlitres of the standardised COX-1
enzyme preparation, and 50μl (per sample) of co-factor
solution (0.003g L-adrenalin/l-epinephrine and 0.003g
reduced glutathione in 10ml; 0.1M Tris buffer, pH 8.2) were
preincubated for 15min on ice. This solution (60μl) was
added to the test solution (2.5μl of ethanol extract + 17.5μl
water) and preincubated for 5min at room temperature. 14C-
arachidonic acid (20μl) was added to this enzyme-extract-
mixture and incubated for exactly 8min in a water bath at
37°C. The reaction was terminated with 10μl 2N HCl.
A sample resuspended at 10mg ml-1 solvent was tested in
the assay at a concentration of 250μg ml-1 test solution. In
each test four controls were run (2.5μl ethanol + 17.5μl
water). Two were backgrounds in which the enzyme was
inactivated with HCl before the addition of 14C-arachidonic
acid and which were kept on ice, and two were solvent
blanks. Indomethacin (5μM) was tested in each assay as a
positive control.
Unlabelled prostaglandin carrier solution (0.2mg ml-1) of
unlabelled prostaglandins [PGE2:PGF2 in the ratio 1:1]) was
added to the reaction mixture (4μl per sample), and 14C-
prostaglandins synthesised in the assay were separated
from unmetabolised arachidonic acid by column chromatog-
raphy using silica columns. Silica gel, (Kieselgel 60,
Korngroesse 0.063–0.2mm, 70–230 mesh ASTM) in eluent
1 (hexane:1,4-dioxan:acetic acid [350:150:1 v/v/v]), was
packed to a height of 3cm in Pasteur pipettes stoppered with
glass wool. The assay mixture was applied to the column
with 1ml eluent 1. This was followed by an additional 4ml
eluent 1 to elute the unreacted arachidonic acid, which was
then discarded. The prostaglandins were then eluted into
scintillation vials using 3ml eluent 2 (ethyl acetate:methanol
[85:15v/v]). Scintillation fluid (4ml) was added and the
radioactivity was counted after 1h in the dark, using a
Beckman LS3801 scintillation counter.
Calculation of inhibition
The percentage inhibition of the extracts was obtained by
measuring the amount of radioactivity in the solutions rela-
tive to that of the solvent blank. Inhibition refers to the reduc-
tion of prostaglandin formation with reference to an untreat-
ed sample (solvent blank). To calculate the % inhibition, the
background DPM value was subtracted from the DPM
measurements of the sample and the solvent blank. The
ratio of the resultant DPM values for the sample to the sol-
vent blank was converted to a percentage. All samples were
tested in triplicate.
Statistical analyses were based on the results obtained from
3 different samples. One-way ANOVA and Tukey HSD tests
were performed using Minitab Xtra version 10.52. The results
of the statistical analyses are presented on the graphs.
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Results and Discussion
Growth data
Bulbs kept in cold storage maintained their fresh mass at a
higher level than did both the dry storage, and leaving the
bulbs in soil, during winter (Figure 1A). Those bulbs kept in
the soil had a significantly lower dry mass than those stored
dry or cold. No significant differences were observed in the
root dry mass, but the fresh mass of roots harvested from
plants that remained in the soil was significantly higher than
that of plants stored  dry or cold (Figure 1B). The moisture in
the soil prevented the roots from drying out to the same
extent as those of the specimens stored dry or cold. The
ratio of fresh to dry mass was highest for the bulbs and roots
of those specimens kept in soil (Figure 2). This also indi-
cates the higher water content of these specimens. There
was no difference in this ratio between the specimens stored
dry or cold.
A second group of plants was harvested mid-way through
the summer season to determine the regenerative ability of
the bulbs after storage. The bulbs kept in cold storage were
slower to develop leaves, with both fresh and dry leaf mass
accumulation significantly lower than those of plants stored
dry or in the soil (Figure 3A). Specimens from the latter two
categories did not differ significantly from each other in this
respect. Bulb fresh mass showed no significant differences
across treatments, while the dry mass of the bulbs stored
cold was significantly lower compared to the bulbs stored in
the soil, but not compared to those stored dry (Figure 3B).
Root fresh and dry mass accumulation was slower for bulbs
that had been stored cold (Figure 3C).
The ratio of fresh to dry mass did not differ significantly for
the leaves (Figure 4), indicating that the delay in leaf emer-
gence was the probable cause of the lower fresh and dry
mass of the leaves in the bulbs stored cold, rather than a
change in growth parameters. With respect to the bulbs
stored in cold conditions, the fresh to dry mass ratios for the
bulbs and roots were significantly higher than that for the
plants stored in the soil or dry, which could correspond to the
observed delay in leaf emergence and consequently higher
reserves still in the bulbs (Figure 4).
Anti-inflammatory activity
Prostaglandins are the primary mediators of the body’s
response to pain and inflammation, and are formed from
essential fatty acids found in cell membranes (Campbell
1990). This reaction is catalysed by cyclooxygenase, a
membrane-associated enzyme (Smith 1990, Goetzel et al.
1995). Non-steroidal anti-inflammatory drugs (NSAIDs) act
by inhibiting the activity of cyclooxygenase (COX), the rate-
limiting step in the formation of prostaglandins from arachi-
donic acid (Vane and Botting 1995). The pharmacological
studies reported here were based on the cyclooxygenase-1
assay, a mechanism-based assay that tests for the pres-
ence of NSAIDs by measuring the degree of inhibition of the
COX-1 enzyme, which is active in prostaglandin synthesis.
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Figure 1: Variation in fresh () and dry () mass of E. autumnalis
autumnalis specimens at Harvest 1. Bulbs stored dry (potting shed);
in soil (greenhouse) (Control); or cold (10°C) during winter. (A)
Variation in bulb growth; and (B) Variation in root growth. (Bars
bearing different letters are significantly different, P ≤ 0.05)
Figure 2: Variation in the ratio of fresh mass to dry mass of bulbs
() and roots () of E. autumnalis autumnalis specimens at
Harvest 1. Bulbs stored dry (potting shed); in soil (greenhouse)
(Control); or cold (10°C) during winter. (Bars bearing different letters
are significantly different, P ≤ 0.05)
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Inhibition can be caused by denaturing (or destroying) the
enzyme, or by acting on the prosthetic group, thus inactivat-
ing the enzyme (Tunón et al. 1995).
The COX-1 inhibitory activity determined at the end of win-
ter was significantly lower from bulbs stored in the soil, with
little difference exhibited between extracts from bulbs stored
dry or cold (Figure 5). The activity of the root extracts did not
differ significantly between treatments.
Extracts prepared from the second harvest of plants (mid-
way through summer) showed high levels of COX-1 inhibito-
ry activity in the leaf extracts from plants that had undergone
cold storage (Figure 6). Part of this increased activity could
be due to the younger physiological status of the leaves.
Previous investigations (Taylor and Van Staden 2001b)
showed higher levels of COX-1 inhibitory activity in leaf
extracts prepared from younger plant specimens, and from
micropropagated plants that had been acclimatised. As the
plant aged, no significant differences were observed in the
levels of COX-1 inhibitory activity in the different plant parts
(Taylor and Van Staden 2001b). A common feature to all
these examples is a higher water content in the plant mate-
rial. No significant difference was detected in the activity of
the various bulb or root extracts (Figure 6).
Storing the bulbs under cold conditions, at 10°C (in a col-
droom) during winter significantly increased the levels of
anti-inflammatory activity shown by the bulb extracts (but not
the root extracts) at the end of the winter season (Figure 5).
After a period of growth during summer, this activity dropped
to a level comparable to extracts from plants stored in the
soil and those stored dry. At this stage, however, higher lev-
els of activity were observed in the leaf extracts from these
plants (Figure 6). These differences could be associated
with changes in the water content of the plant parts.
Small-scale farming of indigenous medicinal plants has
been proposed as a venture for providing an alternative
source of these plants thus alleviating pressure on rapidly
shrinking natural populations (Van Staden 1999). The over-
exploitation of traditional medicinal plants is a major factor in
their current scarcity in the wild. In addition, such ventures
can provide valuable income and employment for impover-
Taylor and Van Staden
Figure 3: Variation in fresh () and dry () mass of E. autumnalis
autumnalis specimens at Harvest 2. Bulbs stored dry (potting shed);
in soil (greenhouse) (Control); or cold (10°C) during winter. (A)
Variation in leaf growth; (B) Variation in bulb growth; and (C)
Variation in root growth. (Bars bearing different letters are signifi-
cantly different, P ≤ 0.05)
Figure 4: Variation in the ratio of fresh mass to dry mass of leaves
(), bulbs () and roots () of E. autumnalis autumnalis specimens
at Harvest 2. Bulbs stored dry (potting shed); in soil (greenhouse)
(Control); or cold (10°C) during winter. (Bars bearing different letters
are significantly different, P ≤ 0.05)
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ished rural populations. To optimise both rapid growth, and
the levels of pharmacologically active compounds, in the
crop species, studies into environmental factors affecting
these parameters need to be established. Studies such as
the one presented here, and in previous reports (Taylor and
Van Staden, 2001b), provide the first step in this process
and should be followed by field trials. These results can
have further implications for the practitioners of traditional
medicine. Collection and storage of medicinal plant material
is a growing business, increasingly practiced by those
untrained in the traditional ways. With the potency of the
plant material affected by the growth conditions and storage
conditions, it is important to educate the gatherers and sell-
ers of the plants in the best way to standardise and preserve
the plant samples on sale.
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